POU2F2 identified as a key oncogenic and immunomodulatory factor in kidney cancer
POU2F2 is upregulated in kidney renal clear cell carcinoma and correlates with poor prognosis and macrophage polarization.
Asset / Drug
Drug and asset intelligence for POU2F2 with 2 indexed intelligence signals across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.